Chang‐Yu Yan

629 total citations
21 papers, 331 citations indexed

About

Chang‐Yu Yan is a scholar working on Molecular Biology, Epidemiology and Pharmacology. According to data from OpenAlex, Chang‐Yu Yan has authored 21 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Epidemiology and 3 papers in Pharmacology. Recurrent topics in Chang‐Yu Yan's work include Inflammasome and immune disorders (3 papers), Herpesvirus Infections and Treatments (3 papers) and interferon and immune responses (2 papers). Chang‐Yu Yan is often cited by papers focused on Inflammasome and immune disorders (3 papers), Herpesvirus Infections and Treatments (3 papers) and interferon and immune responses (2 papers). Chang‐Yu Yan collaborates with scholars based in China, Thailand and Macao. Chang‐Yu Yan's co-authors include Rong‐Rong He, Hiroshi Kurihara, Wen Li, Zhuo Luo, Yi-Fang Li, Haibiao Gong, Wen‐Jun Duan, Shu‐Hua Ouyang, Yanping Wu and Wan‐Yang Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Chang‐Yu Yan

20 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chang‐Yu Yan China 9 141 77 77 50 47 21 331
Meizhou Huang China 16 233 1.7× 77 1.0× 59 0.8× 37 0.7× 40 0.9× 31 569
Yue Wan China 11 314 2.2× 46 0.6× 73 0.9× 26 0.5× 72 1.5× 22 506
Xiangfeng Zhao China 10 153 1.1× 147 1.9× 129 1.7× 34 0.7× 42 0.9× 25 478
Kunpeng Zhu China 7 233 1.7× 35 0.5× 59 0.8× 24 0.5× 88 1.9× 10 425
Minjun Yao China 8 135 1.0× 34 0.4× 72 0.9× 23 0.5× 29 0.6× 8 363
Wuying Lang China 11 124 0.9× 32 0.4× 58 0.8× 40 0.8× 38 0.8× 19 318
Wenchang Zhao China 12 181 1.3× 87 1.1× 31 0.4× 25 0.5× 31 0.7× 26 420
Darasaguppe R. Harish India 15 196 1.4× 38 0.5× 32 0.4× 25 0.5× 50 1.1× 37 424
Peiping Xu China 11 117 0.8× 87 1.1× 96 1.2× 56 1.1× 70 1.5× 19 400

Countries citing papers authored by Chang‐Yu Yan

Since Specialization
Citations

This map shows the geographic impact of Chang‐Yu Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Yu Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Yu Yan more than expected).

Fields of papers citing papers by Chang‐Yu Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang‐Yu Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Yu Yan. The network helps show where Chang‐Yu Yan may publish in the future.

Co-authorship network of co-authors of Chang‐Yu Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Chang‐Yu Yan. A scholar is included among the top collaborators of Chang‐Yu Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang‐Yu Yan. Chang‐Yu Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Ning, Xiaohua Liu, Liangliang He, et al.. (2025). SIRT5: a potential target for discovering bioactive natural products. Journal of Natural Medicines. 79(3). 441–464. 2 indexed citations
2.
Yan, Chang‐Yu, Si Tan, Shisheng Chen, et al.. (2025). Screening novel anti-inflammatory peptides inhibiting the NLRP3 inflammasome from UHPLC-MS/MS-characterized peptide profiles of cocoa tea protein hydrolysates. Food Research International. 212. 116519–116519.
3.
Tan, Xinyu, et al.. (2025). Neurogenic differentiation 2 promotes inflammatory activation of macrophages in doxorubicin-induced myocarditis via regulating protein kinase D. BMC Cardiovascular Disorders. 25(1). 195–195. 1 indexed citations
4.
Yan, Chang‐Yu, Si Tan, Jiang‐Gao Mao, et al.. (2025). Lipid peroxidation inhibition by icaritin and its glycosides as a strategy to combat iron overload-induced osteoporosis in zebrafish. Food Research International. 203. 115900–115900. 1 indexed citations
5.
Li, Xiyou, Xiaomin Li, Qin Yu, et al.. (2024). Supplementation with carnosine, a food‐derived bioactive dipeptide, alleviates dexamethasone‐induced oxidative stress and bone impairment via the NRF2 signaling pathway. Journal of the Science of Food and Agriculture. 105(2). 1091–1104. 3 indexed citations
6.
Zhang, Qiongyi, Fang Wu, Chang‐Yu Yan, et al.. (2024). Antioxidant dipeptide, cyclo (Phe-Phe), protects against bone dysplasia by suppression of phospholipid peroxidation. 1(2). 100003–100003. 4 indexed citations
7.
Yan, Chang‐Yu, Qianqian Zhu, Haibiao Gong, et al.. (2024). Antioxidant and Anti-Inflammatory Properties of Hydrolyzed Royal Jelly Peptide in Human Dermal Fibroblasts: Implications for Skin Health and Care Applications. Bioengineering. 11(5). 496–496. 7 indexed citations
8.
9.
Li, Weixi, Haibiao Gong, Qiongyi Zhang, et al.. (2023). Potential of Tamarind Shell Extract against Oxidative Stress In Vivo and In Vitro. Molecules. 28(4). 1885–1885. 12 indexed citations
10.
Yan, Chang‐Yu, Ye Yue, Yanping Wu, et al.. (2023). Prenatal hormone stress triggers embryonic cardiac hypertrophy outcome by ubiquitin-dependent degradation of mitochondrial mitofusin 2. iScience. 27(1). 108690–108690. 2 indexed citations
11.
Li, Wen, Lianxiang Luo, Qingqing Zhou, et al.. (2022). Phospholipid peroxidation inhibits autophagy via stimulating the delipidation of oxidized LC3-PE. Redox Biology. 55. 102421–102421. 25 indexed citations
12.
Yan, Chang‐Yu, Jie Sun, Qiongyi Zhang, et al.. (2022). Tripeptide Leu‐Pro‐Phe from Corn Protein Hydrolysates Attenuates Hyperglycemia‐Induced Neural Tube Defect in Chicken Embryos. Oxidative Medicine and Cellular Longevity. 2022(1). 4932304–4932304. 7 indexed citations
13.
Zhang, Qiongyi, Chang‐Yu Yan, Xiaomin Li, et al.. (2022). Cyclo(-Phe-Phe) alleviates chick embryo liver injuryviaactivating the Nrf2 pathway. Food & Function. 13(13). 6962–6974. 6 indexed citations
14.
Jiang, Yingnan, et al.. (2022). Indirubin suppresses 4T1 murine breast cancer in vitro and in vivo by induction of ferroptosis. 5(1). 31–31. 1 indexed citations
15.
Luo, Zhuo, Lifang Liu, Yingnan Jiang, et al.. (2020). Novel insights into stress-induced susceptibility to influenza: corticosterone impacts interferon-β responses by Mfn2-mediated ubiquitin degradation of MAVS. Signal Transduction and Targeted Therapy. 5(1). 202–202. 23 indexed citations
16.
Luo, Zhuo, Qingqing Zhou, Chang‐Yu Yan, et al.. (2020). Inhibitory effects of baicalein against herpes simplex virus type 1. Acta Pharmaceutica Sinica B. 10(12). 2323–2338. 56 indexed citations
17.
Li, Wen, Zhuo Luo, Chang‐Yu Yan, et al.. (2020). Autophagic degradation of PML promotes susceptibility to HSV-1 by stress-induced Corticosterone. Theranostics. 10(20). 9032–9049. 12 indexed citations
18.
Yan, Chang‐Yu, Shu‐Hua Ouyang, Xi Wang, et al.. (2020). Celastrol ameliorates Propionibacterium acnes/LPS-induced liver damage and MSU-induced gouty arthritis via inhibiting K63 deubiquitination of NLRP3. Phytomedicine. 80. 153398–153398. 67 indexed citations
19.
Luo, Zhuo, Lifang Liu, Xiaohua Wang, et al.. (2019). Epigoitrin, an Alkaloid From Isatis indigotica, Reduces H1N1 Infection in Stress-Induced Susceptible Model in vivo and in vitro. Frontiers in Pharmacology. 10. 78–78. 49 indexed citations
20.
Li, Wen, Xiaohua Wang, Zhuo Luo, et al.. (2018). Traditional Chinese Medicine as a Potential Source for HSV-1 Therapy by Acting on Virus or the Susceptibility of Host. International Journal of Molecular Sciences. 19(10). 3266–3266. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026